Authors:
Yokota, A
Narazaki, M
Shima, Y
Murata, N
Tanaka, T
Suemura, M
Yoshizaki, K
Fujiwara, H
Tsuyuguchi, I
Kishimoto, T
Citation: A. Yokota et al., Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells, J RHEUMATOL, 28(9), 2001, pp. 1952-1959
Authors:
Verhoef, CM
van Roon, JAG
Vianen, ME
Bijlsma, JWJ
Lafeber, FPJG
Citation: Cm. Verhoef et al., Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis, J RHEUMATOL, 28(9), 2001, pp. 1960-1966
Authors:
van der Laan, W
Molenaar, E
Ronday, K
Verheijen, J
Breedveld, F
Greenwald, R
Dijkmans, B
TeKoppele, J
Citation: W. Van Der Laan et al., Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial, J RHEUMATOL, 28(9), 2001, pp. 1967-1974
Citation: L. Daza et al., Carpal collapse in rheumatoid arthritis - Prevalence and clinical significance: A preliminary study, J RHEUMATOL, 28(9), 2001, pp. 1975-1978
Authors:
Kalden, JR
Scott, DL
Smolen, JS
Schattenkirchner, M
Rozman, B
Williams, BD
Kvien, TK
Jones, P
Williams, RB
Oed, C
Rosenburg, R
Citation: Jr. Kalden et al., Improved functional ability in patients with rheumatoid arthritis - Longterm treatment with leflunomide versus sulfasalazine, J RHEUMATOL, 28(9), 2001, pp. 1983-1991
Citation: Ab. Mongey et E. Hess, In vitro production of antibodies to histones in patients receiving chronic procainamide therapy, J RHEUMATOL, 28(9), 2001, pp. 1992-1998
Citation: Yh. Lee et al., Fas promoter-670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus, J RHEUMATOL, 28(9), 2001, pp. 2008-2011
Authors:
Sipka, S
Szanto, S
Szucs, K
Kovacs, I
Kiss, E
Antal-Szalmas, P
Lakos, G
Aleksza, M
Illes, A
Gergely, P
Szegedi, G
Citation: S. Sipka et al., Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus, J RHEUMATOL, 28(9), 2001, pp. 2012-2017
Citation: Ke. Hansen et al., Risk factors associated with thrombosis in patients with antiphospholipid antibodies, J RHEUMATOL, 28(9), 2001, pp. 2018-2024
Citation: Pj. Nietert et al., Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis, J RHEUMATOL, 28(9), 2001, pp. 2031-2037
Citation: Ha. Kim et al., Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage, J RHEUMATOL, 28(9), 2001, pp. 2038-2045
Authors:
Chintalacharuvu, SR
Urankar-Nagy, N
Petersilge, CA
Abdul-Karim, FW
Emancipator, SN
Citation: Sr. Chintalacharuvu et al., Treatment of collagen induced arthritis by proteolytic enzymes: Immunomodulatory and disease modifying effects, J RHEUMATOL, 28(9), 2001, pp. 2049-2059
Authors:
Gay, RE
Neidhart, M
Pataky, F
Tries, S
Laufer, S
Gay, S
Citation: Re. Gay et al., Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis, J RHEUMATOL, 28(9), 2001, pp. 2060-2065
Authors:
Trudel, G
Desaulniers, N
Uhthoff, HK
Laneuville, O
Citation: G. Trudel et al., Different levels of COX-1 and COX-2 enzymes in synoviocytes and chondrocytes during joint contracture formation, J RHEUMATOL, 28(9), 2001, pp. 2066-2074
Authors:
Quintero, M
Colantuoni, G
Khatib, AM
Panasyuk, A
Lomri, A
Mitrovic, DR
Citation: M. Quintero et al., Granulocyte-macrophage colony stimulating factor activates proteoglycan, type II collagen, and cAMP production by rat articular chondrocytes through specific binding sites, J RHEUMATOL, 28(9), 2001, pp. 2075-2084